首站-论文投稿智能助手
典型文献
Repurposed anti-cancer epidermal growth factor receptor inhibitors:mechanisms of neuroprotective effects in Alzheimer's disease
文献摘要:
Numerous molecular mechanisms are being examined in an attempt to discover disease-modifying drugs to slow down the underlying neurodegeneration in Alzheimer's disease.Recent studies have shown the beneficial effects of epidermal growth factor receptor inhibitors on the enhancement of behavioral and pathological sequelae in Alzheimer's disease.Despite the promising effects of epidermal growth factor receptor inhibitors in Alzheimer's disease,there is no irrefutable neuroprotective evidence in well-established animal models using epidermal growth factor receptor inhibitors due to many un-explored downstream signaling pathways.This caused controversy about the potential involvement of epidermal growth factor receptor inhibitors in any prospective clinical trial.In this review,the mystery beyond the under-investigation of epidermal growth factor receptor in Alzheimer's disease will be discussed.Furthermore,their molecular mechanisms in neurodegeneration will be explained.Also,we will shed light on SARS-COVlD-19 induced neurological manifestations mediated by epidermal growth factor modulation.Finally,we will discuss future perspectives and under-examined epidermal growth factor receptor downstream signaling pathways that warrant more exploration.We conclude that epidermal growth factor receptor inhibitors are novel effective therapeutic approaches that require further research in attempts to be repositioned in the delay of Alzheimer's disease progression.
文献关键词:
作者姓名:
Heba M.Mansour;Hala M.Fawzy;Aiman S.EI-Khatib;Mahmoud M.Khattab
作者机构:
Department of Pharmacology,Egyptian Drug Authority,EDA,formerly NODCAR,Giza,Egypt;Department of Pharmacology and Toxicology,Faculty of Pharmacy,Cairo University,Cairo,Egypt
引用格式:
[1]Heba M.Mansour;Hala M.Fawzy;Aiman S.EI-Khatib;Mahmoud M.Khattab-.Repurposed anti-cancer epidermal growth factor receptor inhibitors:mechanisms of neuroprotective effects in Alzheimer's disease)[J].中国神经再生研究(英文版),2022(09):1913-1918
A类:
Repurposed,irrefutable
B类:
anti,cancer,epidermal,growth,receptor,inhibitors,mechanisms,neuroprotective,effects,Alzheimer,disease,Numerous,molecular,are,being,examined,discover,modifying,drugs,slow,underlying,neurodegeneration,Recent,studies,have,shown,beneficial,enhancement,behavioral,pathological,sequelae,Despite,promising,there,evidence,well,established,animal,models,using,due,many,explored,downstream,signaling,pathways,This,caused,controversy,about,potential,involvement,prospective,clinical,trial,In,this,review,mystery,beyond,investigation,will,discussed,Furthermore,their,explained,Also,light,SARS,COVlD,induced,neurological,manifestations,mediated,by,modulation,Finally,future,perspectives,that,warrant,exploration,We,conclude,novel,effective,therapeutic,approaches,require,further,research,attempts,repositioned,delay,progression
AB值:
0.518896
相似文献
Globular adiponectin-mediated vascular remodeling by affecting the secretion of adventitial-derived tumor necrosis factor-αinduced by urotensin Ⅱ
Jun LI;Limin LUO;Yonggang ZHANG;Xiao DONG;Shuyi DANG;Xiaogang GUO;Wenhui DING-Department of Cardiology,the First Affiliated Hospital,Zhejiang University School of Medicine,Hangzhou 310003,China;Division of Cardiology,Department of Internal Medicine,Taihe Hospital,Hubei University of Medicine,Shiyan 442000,China;Division of Cardiology,Department of Internal Medicine,Peking University First Hospital,Beijing 100034,China;Department of Dermatology,the First Affiliated Hospital,Zhejiang University School of Medicine,Hangzhou 310003,China;Department of Cardiovascular Diseases,the Second Affiliated Hospital,Shantou University Medical College,Shantou 515041,China
EGFR signaling promotes nuclear translocation of plasma membrane protein TSPAN8 to enhance tumor progression via STAT3-mediated transcription
Xiaoqing Lu;Liwei An;Guangjian FanTi;Lijuan Zang;Weiyi Huang;Junjian Li;Jun Liu;Weiyu Ge;Yuwei Huang;Jingxuan Xu;Shaoqian Du;Yuan Cao;Tianhao Zhou;Huijing Yin;Li Yu;Shi Jiao;Hongxia Wang-State Key Laboratory of Oncogenes and Related Genes,Department of Oncology,Shanghai General Hospital,Shanghai Jiao Tong University School of Medicine,Shanghai,China;Department of Breast Surgery,Shanxi Cancer Hospital,Chinese Academy of Medical Sciences,Taiyuan,Shanxi,China;Department of Medical Ultrasound,Shanghai Tenth People's Hospital,Tongji University Cancer Center,School of Medicine,Tongji University,Shanghai,China;Precision Research Center for Refractory Diseases,Institute for Clinical Research,Shanghai General Hospital,Shanghai Jiao Tong University School of Medicine,Shanghai,China;Department of Pathology,Shanghai General Hospital,Shanghai Jiao Tong University School of Medicine,Shanghai,China;State Key Laboratory of Membrane Biology,Tsinghua-Peking University Joint Center for Life Sciences,School of Life Science,Tsinghua University,Beijing,China;State Key Laboratory of Genetic Engineering,School of Life Sciences,Fudan University,Shanghai,China
Novel dual inhibitor for targeting PIM1 and FGFR1 kinases inhibits colorectal cancer growth in vitro and patient-derived xenografts in vivo
Fanxiang Yin;Ran Zhao;Dhilli Rao Gorja;Xiaorong Fu;Ning Lu;Hai Huang;Beibei Xu;Hanyong Chen;Jung-Hyun Shim;Kangdong Liu;Zhi Li;Kyle Vaughn Laster;Zigang Dong;Mee-Hyun Lee-Department of Pathophysiology,School of Basic Medical Sciences,Zhengzhou University,Zhengzhou 450001,China;China-US(Henan)Hormel Cancer Institute,Zhengzhou 450008,China;Translational Medical Center,the First Affiliated Hospital of Zhengzhou University,Zhengzhou 450052,China;The Hormel Institute,University of Minnesota,Austin,MN 55912,USA;Department of Biomedicine,Health&Life Convergencen Science,BK21 Four,College of Pharmacy,Mokpo National University,Jeonnam 58554,Republic of Korea;The Collaborative Innovation Center of Henan Province for Cancer Chemoprevention,Zhengzhou 450001,China;Department of General Surgery,the Affiliated Tumor Hospital of Zhengzhou University,Zhengzhou 450008,China;College of Korean Medicine,Dongshin University,Naju 58245,Republic of Korea
Abivertinib inhibits megakaryocyte differentiation and platelet biogenesis
Jiansong Huang;Xin Huang;Yang Li;Xia Li;Jinghan Wang;Fenglin Li;Xiao Yan;Huanping Wang;Yungui Wang;Xiangjie Lin;Jifang Tu;Daqiang He;Wenle Ye;Min Yang;Jie Jin-Department of Hematology,Key Laboratory of Hematologic Malignancies,Diagnosis and Treatment,The First Affiliated Hospital,Zhejiang University School of Medicine,Hangzhou 310003,China;Institute of Hematology,Zhejiang University School of Medicine,Hangzhou 310003,China;Department of Obstetrics,The First Affiliated Hospital,Zhejiang University School of Medicine,Hangzhou 310003,China;Department of Hematology,Qingdao Municipal Hospital,Qingdao 266000,China;Department of Laboratory Medicine,Affiliated Hangzhou First People's Hospital,Zhejiang University School of Medicine,Hangzhou 310003,China;Cancer Center Zhejiang University,Hangzhou 310058,China
机标中图分类号,由域田数据科技根据网络公开资料自动分析生成,仅供学习研究参考。